Treatment aplastic anemia children recombinant human granulocyte colony-stimulating factor Twenty children years severe moderate aplastic anemia recombinant human granulocyte colony-stimulating factor rhG-CSF dose day intravenous IV infusion weeks treatment neutrophil counts patients doses day patients initial dose increase neutrophil count Differential counts bone marrow BM increase myeloid/erythroid ratio response transient neutrophil count days treatment severe toxicity attributable rhG-CSF results agent effective granulopoiesis children aplastic anemia study rhG-CSF useful patients aplastic anemia bacterial fungal infection 